Successfully Piloting a Virtual Real-World Evidence Study Case StudyCovance
A mid-sized pharmaceutical company needed to conduct a completely virtual study and asked Covance to support their efforts based on their past experience with virtual real-world evidence programs.
Expanding Patient Enrollment and Site Activation Study Case Study: Partnershi...Covance
Clinical development services are often only partially outsourced. Some sponsors prefer to manage the trial themselves due to an affinity for the science involved or perception that the trial's complexity is better handled internally. For this reason, a flexible partner is ideal to ensure the sponsor's needs are being met efficiently and effectively.
Successfully Piloting a Virtual Real-World Evidence Study Case StudyCovance
A mid-sized pharmaceutical company needed to conduct a completely virtual study and asked Covance to support their efforts based on their past experience with virtual real-world evidence programs.
Expanding Patient Enrollment and Site Activation Study Case Study: Partnershi...Covance
Clinical development services are often only partially outsourced. Some sponsors prefer to manage the trial themselves due to an affinity for the science involved or perception that the trial's complexity is better handled internally. For this reason, a flexible partner is ideal to ensure the sponsor's needs are being met efficiently and effectively.
The healthcare industry has gone and continues to go through major systems transformation, and healthcare providers need to be ready to implement and adapt to such rapid changes. At DAO our focus is helping you achieve your operational, clinical, and quality goals by navigating quality and regulatory challenges, and adapting practical and consistent solutions that can be implemented and sustained at all levels of the organization.
DAO is a healthcare strategic management consulting firm with over 9 years experience serving healthcare institutions and community-based organizations, with a focus on industries transformation.
FLAACOs 2014 Conference - Improving Outcomes and Reducing Costs Through Activ...MARCYINC
Improving Outcomes and Reducing Costs Through Active Care Coordination and TEAM Based Care presented by Alan Gilbert at the FLAACOs 2014 Fall Conference
Whirlpool Corporation is the world’s leading manufacturer and marketer of major home appliances, with annual sales over $19 billion, more than 80,000 employees and more than 60 manufacturing and technology research centers globally. Consumers around the world enjoy Whirlpool’s innovative products marketed under Whirlpool, Maytag, KitchenAid, Jenn-Air, Amana, Brastemp, Bauknecht and other major brand names. With this varied inventory, plus a large direct sales force in more than 170 countries and an unpredictable sales cycle, effective supply chain management is critical for continued growth. Whirlpool has not always considered logistics a competitive advantage. However, since naming Penske as lead logistics supplier, Whirlpool experienced cost savings, increased customer satisfaction and found a partner to help integrate the recent acquisition of Maytag.
Putting the Patient First: Launching a Comprehensive Patient-Centric ProgramCovance
Following a successful sponsor/CRO partnership in which Covance supported a large sponsor's reimbursement call center, a solid partnership had formed, founded on trust and a shared culture. The sponsor expanded this partnership with Covance with the desire to seamlessly transition another reimbursement support program from their current vendor. With the additional successful execution of this project, the sponsor selected Covance as their partner to consolidate all existing hub programs, build a tailored customer relationship management (CRM) tool and develop programs focused on the sponsor's specific needs and enhanced new therapeutic areas and markets.
The healthcare industry has gone and continues to go through major systems transformation, and healthcare providers need to be ready to implement and adapt to such rapid changes. At DAO our focus is helping you achieve your operational, clinical, and quality goals by navigating quality and regulatory challenges, and adapting practical and consistent solutions that can be implemented and sustained at all levels of the organization.
DAO is a healthcare strategic management consulting firm with over 9 years experience serving healthcare institutions and community-based organizations, with a focus on industries transformation.
The healthcare industry has gone and continues to go through major systems transformation, and healthcare providers need to be ready to implement and adapt to such rapid changes. At DAO our focus is helping you achieve your operational, clinical, and quality goals by navigating quality and regulatory challenges, and adapting practical and consistent solutions that can be implemented and sustained at all levels of the organization.
DAO is a healthcare strategic management consulting firm with over 9 years experience serving healthcare institutions and community-based organizations, with a focus on industries transformation.
FLAACOs 2014 Conference - Improving Outcomes and Reducing Costs Through Activ...MARCYINC
Improving Outcomes and Reducing Costs Through Active Care Coordination and TEAM Based Care presented by Alan Gilbert at the FLAACOs 2014 Fall Conference
Whirlpool Corporation is the world’s leading manufacturer and marketer of major home appliances, with annual sales over $19 billion, more than 80,000 employees and more than 60 manufacturing and technology research centers globally. Consumers around the world enjoy Whirlpool’s innovative products marketed under Whirlpool, Maytag, KitchenAid, Jenn-Air, Amana, Brastemp, Bauknecht and other major brand names. With this varied inventory, plus a large direct sales force in more than 170 countries and an unpredictable sales cycle, effective supply chain management is critical for continued growth. Whirlpool has not always considered logistics a competitive advantage. However, since naming Penske as lead logistics supplier, Whirlpool experienced cost savings, increased customer satisfaction and found a partner to help integrate the recent acquisition of Maytag.
Putting the Patient First: Launching a Comprehensive Patient-Centric ProgramCovance
Following a successful sponsor/CRO partnership in which Covance supported a large sponsor's reimbursement call center, a solid partnership had formed, founded on trust and a shared culture. The sponsor expanded this partnership with Covance with the desire to seamlessly transition another reimbursement support program from their current vendor. With the additional successful execution of this project, the sponsor selected Covance as their partner to consolidate all existing hub programs, build a tailored customer relationship management (CRM) tool and develop programs focused on the sponsor's specific needs and enhanced new therapeutic areas and markets.
The healthcare industry has gone and continues to go through major systems transformation, and healthcare providers need to be ready to implement and adapt to such rapid changes. At DAO our focus is helping you achieve your operational, clinical, and quality goals by navigating quality and regulatory challenges, and adapting practical and consistent solutions that can be implemented and sustained at all levels of the organization.
DAO is a healthcare strategic management consulting firm with over 9 years experience serving healthcare institutions and community-based organizations, with a focus on industries transformation.
Develop a 5-7 page implementation plan addressing the various factors.docxrosaliaj1
Develop a 5-7 page implementation plan addressing the various factors critical to the successful deployment of the new or upgraded telehealth technology that was the focus of the previous two assessments. Introduction Technology continues to move at an accelerated pace, and the delivery of health care is shifting from office-based environments to the home. For this reason, health care organizations must be at technology's cutting edge in order to remain competitive in today's environment. Integrating the daily activities of patients into the health care continuum will improve the quality of care that is provided and enable more holistic care. This assessment provides an opportunity for you to develop an implementation plan that addresses the various factors critical to the successful deployment of the new or upgraded telehealth technology that was the focus of your previous assessments. Preparation Based on the positive reactions and feedback from stakeholders with regard to the proposed telehealth technology, executive leaders have decided to move forward with implementation of this telehealth solution and have asked you to develop the implementation plan. To prepare for the assessment, you are encouraged to reflect on the factors critical to the successful deployment of the new or upgraded telehealth technology and on how such technology would be implemented in your organization or practice setting. In addition, you are encouraged to become familiar with the Systems Development Life Cycle (SDLC) process for successfully implementing information systems or a change model for technology use that you think best supports your technology implementation ideas. Refer to the suggested readings, supplemented, as desired, by your own research. You may also wish to:
· Review the assessment instructions and scoring guide to ensure that you understand the work you will be asked to complete.
· Review the , which includes questions to consider and additional guidance on how to successfully complete the assessment.. Requirements Develop a technology implementation plan that supports the vision for safe, high-quality health care in your organization or practice setting. Complete the simulation. The implementation plan requirements, outlined below, correspond to the grading criteria in the Implementation Plan Scoring Guide, so be sure to address each point. Read the performance-level descriptions for each criterion to see how your work will be assessed. The Guiding Questions: Implementation Plan document, linked above, provides additional considerations that may be helpful in completing your assessment. In addition, be sure to note the requirements below for document format and length and for citing supporting evidence.
· Assess the adequacy of existing telehealth technology infrastructure in your organization or practice setting.
· Assign tasks and responsibilities for deploying the new or upgraded telehealth technology.
· Develop an implementation sch.
Genomics Solutions - Single Target to Whole Genome AnalysisCovance
With applied Genomics expertise, global co-location with Central Labs and solutions from biomarker discovery to CDx, our genomics solutions will help make your Precision Medicine drug development a reality.
Medical Device and Diagnostics Solutions for Every Stage of Your Product's De...Covance
Getting a medical device to the patient takes more than good technology in today's environment. Compelling evidence and convincing value proposition matter. Competing priorities and differing stakeholder definitions of value are driving the need for creative, connected strategies to get the most from each step in the development process. And - as evidence is gathered - it should be used to inform and iterate regulatory, reimbursement and clinical post-market strategies.
Pharmacovigilance Risk Management for BiosimilarsCovance
This paper focuses on pharmacovigilance (PV) and risk management for biosimilars, the issues and challenges faced in monitoring their safety and possible solutions.
Cell & Gene Therapy post-approval solutions to reduce scientific, regulatory and commercial risks, and accelerate development wherever you are in your product's development.
Cell & Gene Therapy enterprise development solutions to reduce scientific, regulatory and commercial risks, and accelerate development wherever you are in your product's development.
Cell & Gene Therapy Clinical Development SolutionsCovance
Cell & Gene Therapy clinical development solutions to reduce scientific, regulatory and commercial risks, and accelerate development wherever you are in your product's development.
Inhalation Technology - The Future of Effective Respiratory TreatmentsCovance
Nonclinical development channels: technical strategies, formulations and devices. Conventionally, inhaled drugs have been used to deliver medicines targeted at the most widespread respiratory diseases - specifically, chronic obstructive pulmonary disease (COPD) and asthma.
The Challenges Associated with Evaluating the Cost Benefit of Gene Therapies ...Covance
Despite the growing availability of approved gene therapies, decision-makers face significant challenges when evaluating pricing and reimbursement of these novel therapeutics. From determining cost-benefit ratios, setting out patient access criteria and designing reimbursement plans, this white paper explores some of the complex aspects of value assessment for gene therapies, and discusses results from a survey of key decision-makers across Germany, Sweden and the UK responsible for making pricing and reimbursement decisions.
Environmental Risk Assessment for Pharmaceutical DrugsCovance
Understanding the Evaluation and Implications of Findings to the Regulatory Review of Human Medicines in the Environment. Pharmaceutical drugs are intended for the treatment of human disease, therefore the risk of their environmental exposure in clinical use needs to be evaluated. Environmental risk assessment (ERA) is part of the requirements when applying for marketing approval in many geographic regions throughout the world.
Getting Investigators Onboard: Lab Preferences Make a Difference in Trial Par...Covance
Clinical trials are becoming increasingly complex and competitive, so attracting the best investigator sites to participate in a trial is a crucial step in meeting patient enrollment targets. Learn more about how investigator preference can help meet trial recruitment milestones.
Top 15 Pharma Gains an Edge in a Highly Competitive Specialty MarketCovance
Due to the complex nature of patient access and reimbursement process for specialty products, the client required a customized hub program to support multiple products, across several therapeutic areas. The unique intricacies of the initiative required a trusted strategic partner who could help advise, inform and support an innovative patient-centric program. In addition to possessing the right expertise and processes, the vendor needed to have a flexible technology platform that could be tailored to support the multiple brand requirements and deliver a seamless experience to various stakeholders including patients, healthcare professionals (HCPs) and specialty pharmacies.
Field Services: Providing On-Site, Field-Based Assistance to Support Customer...Covance
Ensuring access for patients can be complex and impacted by ever-changing factors that require an adaptable and responsive holistic solution to help provider and patients. Relying on a consultative approach, policy expertise and decades of experience, Covance Market Access deploys a variety of different filed-based teams that are tailored to meet your objectives and simplify access for your product.
Overcome the unique challenges of late-phase product development and generate the right data to support your products' objective. Products in late-phase development have complex needs and demands. Programs at this phase support new indications, value communication, adherence strategies, safety and efficacy and more.
Optimizing Each Patient's Product Access ExperienceCovance
Relying on a consultative approach, deep expertise and decades of experience, we work collaboratively with clients to deliver a successful product launch, program transition or program enhancement. Clients benefit from our market insights, strategic and unique approach and ability to continuously refine our processes.
Covance, in partnership with Oracle, offers a full-service, validated, private cloud, single-tenancy solution based on Argus technology, which enables faster and better safety decisions. This automated and integrated solution allows for easy scientific querying and analytics, which improves the quality and efficiency of safety operations. It also enhances compliance with E2B exchange for expedited and periodic reporting, allowing the organization to conduct global case processing, which can scale to tens of thousands of annual cases.
Plant Metabolism Studies: Options for Plant CultivationCovance
Regulators across the world are concerned with ensuring that any residues left in or on a crop after application of a plant protection product (PPP), present minimal risk to the health of humans and animals. To achieve this, regulators need information on the identity of the residues and the levels of residues remaining in or on a crop, in order to assess dietary risk and set maximum residue levels (MRLs). The testing approaches used are harmonized across most countries worldwide, focusing on the Organization for Economic Co-operation and Development (OECD) Test Guidelines (TGs) for pesticide residue chemistry. This e-book paper focuses on the laboratory-based plant cultivation methods that underlie the success of OECD crop metabolism studies, namely TG 501 and 502.
K-REACH - How to Prepare for the K-REACH LegislationCovance
In 2015, South Korea introduced legislation designed to protect human health and the environment from the impact of chemicals. The two pieces of legislation introduced were the: Act on the Registration and Evaluation of Chemicals (K-REACH), which mandates the registration of all new and existing chemicals marketed or imported into South Korea at ≥1 metric ton per year, requiring detailed information on their likely hazard to human health and the environment and the Chemicals Control Act (CCA), which focuses on chemical reporting and chemical accident prevention.
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
Basavarajeeyam is an important text for ayurvedic physician belonging to andhra pradehs. It is a popular compendium in various parts of our country as well as in andhra pradesh. The content of the text was presented in sanskrit and telugu language (Bilingual). One of the most famous book in ayurvedic pharmaceutics and therapeutics. This book contains 25 chapters called as prakaranas. Many rasaoushadis were explained, pioneer of dhatu druti, nadi pareeksha, mutra pareeksha etc. Belongs to the period of 15-16 century. New diseases like upadamsha, phiranga rogas are explained.
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
Scaling Up For Savings with Global Monitoring FSPx Relationship
1. Scaling Up for Savings
with a Flexible Global
Monitoring FSPx Relationship
Case Study
A large pharmaceutical company was exploring options for more cost-effective monitoring of their
global clinical studies. This case study highlights how the client transitioned their monitoring
functions to Covance Functional Service Provider (now termed FSPx) services and how their
relationship with Covance has grown to deliver global scalability and single-vendor efficiency
over the last 11 years.
Smoothly Handling Initial Transition
Challenges
In 2008, the sponsor asked Covance FSPx to manage
100 clinical research associates (CRAs) and clinical trial
associates (CTAs) in 40 countries. At the time, the client was
transitioning from multiple FSP providers at a local level to
a more streamlined, efficient approach with Covance as its
single global provider for CRAs.
Although there was some resistance to this change at the
level of the local affiliates, Covance FSPx worked to develop
relationships at the local level by assigning a global account
director, supported by FSPx managers on a regional and local
level who could partner with client affiliate offices. This effort
provided a clear communication track between all affiliates.
To accommodate the unique differences across 40 countries,
Covance FSPx created a custom integration plan that
evaluated each country’s resource requirements, challenges, team culture and dynamics. As a result, the
FSPx team helped ease the transition and ensured that monitoring timelines were met and deliverables
remained on track.
Quickly Ramping Up
Within six months of the completed transition, the client was so pleased with the results that they felt confident in
doubling the number of CRAs and CTAs through the Covance FSPx model.
By 2011, the Covance FSPx provided over 400 CRAs and CTAs. In addition, the client also had asked Covance to handle
the employment of several Project Management groups.
Expanding the FSPx Model with Custom Onboarding and Training Program
After a few years of steady growth with FSPx, the client wanted to expand their Covance FSPx services in 2013 to
include an enhanced full-time employee model. In this “input-based” model, the client assigned the work and retained
responsibility; Covance FSPx directly managed the staff and took responsibility for resource management, developing a
customized training program for onboarding CRAs.
A few years later, Covance FSPx was asked to perform a continual review of
labor laws to ensure compliance in all countries as the total number of
FSPx staff grew from 600 to just over 800 people.
Highlights
Eased the transition of global
clinical monitoring to a single
provider
Created a custom integration
plan across 40 countries
Rapidly expanded growth of
CRA, CTA and PM staffing
Provided flexibility with
employment models and a pilot
FSPx study
Achieved high client satisfaction
rates with FSPx 850 full-time
employees